期刊文献+

白藜芦醇治疗帕金森病的研究进展

Research progress of resveratrol in treating Parkinson's disease
原文传递
导出
摘要 帕金森病(PD)是一种老年神经退行性疾病,由于左旋多巴“替代疗法”的治疗有限,因此,积极寻找多靶点且安全有效的药物对PD的预防和治疗更具意义。白藜芦醇作为从植物中分离的一种天然多酚,已被证实具有极强的神经保护作用,其通过多种途径如抗氧化、抗炎、保护线粒体等方面,防治包括PD在内的许多神经系统疾病。本文综述白藜芦醇针对PD发病机制所发挥的潜在神经保护作用,以期对临床应用白藜芦醇防治PD提供理论参考。 Parkinson's disease(PD)is a neurodegenerative disease in the elderly.Due to the limited therapeutic effect of levodopa"replacement therapy",it is more meaningful to actively search for multi-target,safe and effective drugs for the prevention and treatment of PD.As a natural polyphenol isolated from plants,resveratrol has been confirmed to have strong neuroprotective effects.It can prevent and treat many nervous system diseases including PD through a variety of pathways such as anti-oxidation,anti-inflammation,and mitochondrial protection.This article reviews the potential neuroprotective effects of resveratrol on the pathogenesis of PD,in order to provide theoretical reference for the clinical application of resveratrol in the prevention and treatment of PD.
作者 李媛媛 包小立 汪瑶 王彦春 LI Yuan-yuan;BAO Xiao-Li;WANG Yao;WANG Yan-chun(College of Acupuncture and Chinese Orthopedics,Hubei University of Chinese Medicine,Wuhan 430061;Clinical College of TCM,Hubei University of Chinese Medicine,Wuhan 430065)
出处 《湖北中医药大学学报》 2024年第2期122-126,共5页 Journal of Hubei University of Chinese Medicine
基金 国家自然科学基金项目(项目编号:30973809) 教育部“新世纪优秀人才支持计划”项目(项目编号:NCET-10-0154)。
关键词 白藜芦醇 帕金森病 神经退行性疾病 Resveratrol Parkinson's disease Neurodegenerative diseases
  • 相关文献

参考文献4

二级参考文献33

  • 1Feng Y, Jankovic J, Wu YC. Epigenetic mechanisms in Parkinson's disease. J Neurol Sci, 2015, 349(1-2): 3-9.
  • 2He Q, Koprich JB, Wang Y, et al. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV alpha-Synuclein Rat Model of Parkinson's Disease. Mol Neurobiol, 2015.
  • 3Feng Y, Liu T, Li XQ, et al. Neuroprotection by Orexin-A via HIF-1alpha induction in a cellular model of Parkinson's disease. Neurosci Lett, 2014, 579: 35-40.
  • 4Sajish M, Schimmel P. A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol. Nature, 2015, 519(7543): 370-373.
  • 5Wu Y, Li X, Zhu JX, et al. Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. Neurosignals, 2011, 19(3): 163-174.
  • 6Price NL, Gomes AP, Ling AJ, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab, 2012, 15(5): 675-690.
  • 7Lin JN, Lin VC, Rau KM, et al. Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. J Agric Food Chem, 2010, 58(3): 1584-1592.
  • 8Silvestre MF, Viollet B, Caton PW, et al. The AMPK-SIRT signaling network regulates glucose tolerance under calorie restriction conditions. Life Sci, 2014, 100(1): 55-60.
  • 9Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc, 2007, 2(1): 141-151.
  • 10Blanchet J, Longpre F, Bureau G, et al. Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32(5): 1243-1250.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部